
Bristol Myers to Overhaul R and D Structure
Bristol Myers Squibb announced plans to merge its scientific and clinical teams into a single research and development department. The new structure takes effect January 1 under Chief Medical Officer Cristian Massacesi.
Insights:

Bristol Myers Squibb will merge its scientific and clinical research teams into a single R&D department under Chief Medical Officer Cristian Massacesi, effective January 1, 2027. The restructuring comes as the drugmaker looks to streamline operations and reinvigorate its late-stage drug portfolio. Investors are closely tracking pipeline execution for clear signs of long-term revenue growth.










